Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.
Nazish K HashmiKamrouz GhadimiAmudan J SrinivasanYi-Ju LiRobert D RaiffJeffrey G GacaAdam G RootYaron D BaracThomas L OrtelJerrold H LevyIan J WelsbyPublished in: Vox sanguinis (2019)
3F-PCC use for refractory bleeding after cardiovascular surgery resulted in reduced transfusion of allogeneic blood and blood products. Adherence to this algorithmic approach was associated with an acceptable incidence of postoperative thrombotic/thromboembolic complications.
Keyphrases
- minimally invasive
- coronary artery bypass
- atrial fibrillation
- risk factors
- stem cell transplantation
- surgical site infection
- bone marrow
- patients undergoing
- cardiac surgery
- type diabetes
- low dose
- percutaneous coronary intervention
- coronary artery disease
- weight loss
- skeletal muscle
- adipose tissue
- sickle cell disease